from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0124/PE_PGRS2

LFCtreatmentdescriptionclass of inhibitor

-0.034

Amikacinug/mL Amikacintranslation

0.926

Cap5-10ug/mL Capreomycintranslation

1.170

Rox10-50 ug/mL Roxithromycintranslation

-0.867

SM2-5 ug/mL Streptomycintranslation

0.121

Tet5-10 ug/mL Tetracyclinetranslation

0.210

Rif0.2-5ug/mL Rifampicintranscription

-0.772

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.466

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.610

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.079

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-3.175

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.237

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.655

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.250

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.180

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.139

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

1.965

NaN30.2-2 mM Sodium aziderespiration

-1.930

Nigericin50 uM Nigericinrespiration

-0.690

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.196

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.016

menadione6-10 ug/mL Menadionerespiration

-0.408

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.329

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.155

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.502

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.028

NRP_1Non-replicating persistence stage 1dosRassociated

-0.158

Amp0.2mg/mL AmpicillincellWall

-0.129

Cephalexin20-100 ug/mL CephalexincellWall

-0.528

Cerulenin0.32-5 ug/mL CerulenincellWall

0.526

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.137

EMB10-20 ug/mL EthambutolcellWall

-0.684

Eta12-40 ug/mL EthionamidecellWall

-0.117

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.807

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.239

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.323

BZA0.12 mg/mL BenzamidearomaticAmides

0.675

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.564

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.585

H2O24 mM hydrogen peroxideDNAdamaging

0.204

Levo10 ug/mL LevofloxacinDNAdamaging

0.004

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.611

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.644

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.208

Antimycin12.5-50 ug/mL Antimycin A?

-1.824

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.818

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.059

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.106

PA8240.2-2 ug/mL PA-824?

-1.002

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.012

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.844

Verapamil50 uM Verapamil?

-1.712

mercaptoethanol2 mM 2-Mercaptoethanol?

0.054

methoxatin10-20 ug/mL Methoxatin?